{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:30:12Z","timestamp":1793572212842,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To appraise whether the completion hysterectomy after concurrent chemoradiotherapy (CCRT) would improve the survival outcomes for patients with locally advanced cervical adenocarcinoma (LACA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study was conducted based on a large cohort including more than 200 LACA patients from Peking Union Medical College Hospital. The included patients were divided into the CCRT alone and CCRT + surgery groups, where overall survival (OS), progression-free survival (PFS), loco-regional-free survival (LRFS), and distant metastasis-free survival (DMFS) were compared between the two groups before and after propensity scoring matching (PSM). Cox regression analysis was performed in the CCRT alone group to identify the risk factors impairing the survival probability. The survival outcomes were further compared between the CCRT alone and the CCRT + surgery group in different risk subgroups identified from Cox regression analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      CCRT + surgery was observed to outperform CCRT alone in OS, PFS, LRFS, and DMFS before PSM (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), while the benefit of surgery could not be maintained after PSM except for DMFS (3-year DMFS: 76.8 vs. 60.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.035). Uterus involvement (UI) was identified as the only risk factor for the CCRT alone group. Surgery was found to increase the survival probability for patients with UI (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05), while it did not bring additional survival benefit for patients without UI (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &gt; 0.05). In the CCRT + surgery group, patients with pathological residual disease (RD) \u2265 1\/2 myometrial infiltration (MI) had significantly decreased survival compared to patients with RD&lt;1\/2MI or patients without RD (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Furthermore, postoperative chemotherapy didn\u2019t improve survival outcomes in patients with RD&lt;1\/2MI, while it seemed to bring additional benefit for patients with RD\u22651\/2MI in terms of PFS with marginal significance (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.055).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Completion hysterectomy after CCRT could increase DMFS for LACA patients, while not every LACA patient would retain OS benefit from surgery, except for those with positive UI. Survival differences existed in different degrees of RD among patients receiving post-radiation surgery and postoperative chemotherapy, demonstrating a trend toward PFS benefit for patients with RD\u22651\/2MI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003549","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T10:00:07Z","timestamp":1762336807000},"page":"1274-1283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Appraisal the significance of completion hysterectomy after definitive concurrent chemoradiotherapy for patients with locally advanced cervical adenocarcinoma: the ATTRACT study"],"prefix":"10.1097","volume":"112","author":[{"given":"Xi-Lin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Can","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"You","sequence":"additional","affiliation":[{"name":"Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Lan","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Wei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Fang","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Quan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"},{"name":"Department of Radiation Oncology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"R1-20260518","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Filho","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"998174","DOI":"10.3389\/fpubh.2022.998174","article-title":"Impact of human papillomavirus vaccine on cervical cancer epidemic: evidence from the surveillance, epidemiology, and end results program","volume":"10","author":"Pei","year":"2023","journal-title":"Front Public Health"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"94\u2013101","DOI":"10.1007\/s44197-023-00172-7","article-title":"Global cervical cancer incidence by histological subtype and implications for screening methods","volume":"14","author":"Wang","year":"2024","journal-title":"J Epidemiol Glob Health"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"214\u201326","DOI":"10.1097\/PAS.0000000000000986","article-title":"International endocervical adenocarcinoma criteria and classification (IECC): a new pathogenetic classification for invasive adenocarcinomas of the endocervix","volume":"42","author":"Stolnicu","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"112\u201327","DOI":"10.1111\/his.13995","article-title":"Cervical adenocarcinoma: integration of HPV status, pattern of invasion, morphology and molecular markers into classification","volume":"76","author":"Park","year":"2020","journal-title":"Histopathol"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.3390\/cancers15061730","article-title":"Poor treatment outcomes of locally advanced cervical adenocarcinoma of human papilloma virus independent type, represented by gastric type adenocarcinoma: a multi-center retrospective study (Sankai gynecology study group)","volume":"15","author":"Seki","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/cancers15010170","article-title":"Gastric-type adenocarcinoma of the uterine cervix associated with poor response to definitive radiotherapy","volume":"15","author":"Kuruma","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R8-20260518","first-page":"154\u201363","article-title":"The updated World Health Organization classification better predicts survival in patients with endocervical adenocarcinoma (KROG 20-07)","volume":"117","author":"Kuruma","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"272\u201381","DOI":"10.1002\/ijgo.15388","article-title":"Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: a propensity score-matched real-world analysis","volume":"166","author":"Liang","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13014-018-1197-5","article-title":"Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy","volume":"13","author":"Hu","year":"2018","journal-title":"Radiat Oncol"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/S0020-7292(12)60023-X","article-title":"Cancer of the cervix uteri","volume":"119","author":"Wiebe","year":"2012","journal-title":"Int J Gynaecol Obstet"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.3802\/jgo.2016.27.e40","article-title":"Extrafascial hysterectomy after concurrent chemoradiotherapy in locally advanced cervical adenocarcinoma","volume":"27","author":"Yang","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"R14-20260518","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1097\/IGC.0000000000000263","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma","volume":"24","author":"Fujiwara","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"343\u201353","DOI":"10.1016\/S0090-8258(03)00173-2","article-title":"Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the gynecologic oncology group","volume":"89","author":"Keys","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"357\u201363","DOI":"10.1007\/s13224-024-02053-w","article-title":"Adjuvant hysterectomy in patients after radiation for locally advanced cervical cancer: a single-center prospective longitudinal study","volume":"74","author":"Nanda","year":"2024","journal-title":"J Obstet Gynaecol India"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3892\/mco.2020.2162","article-title":"Post-radiotherapy hysterectomy does not benefit females with cervical adenocarcinoma","volume":"13","author":"Souza","year":"2020","journal-title":"Mol Clin Oncol"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3802\/jgo.2020.31.e16","article-title":"Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery","volume":"31","author":"Yang","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"R19-20260518","first-page":"1\u20137","article-title":"Adjuvant hysterectomy in patients with residual disease after radiation for locally advanced cervical cancer: a prospective longitudinal study","volume":"5","author":"Pervin","year":"2019","journal-title":"J Glob Oncol"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"68\u201373","DOI":"10.1080\/01443615.2018.1463205","article-title":"Completion surgery after chemoradiotherapy for cervical cancer - is there a role? UK cancer centre experience of hysterectomy post chemo-radiotherapy treatment for cervical cancer","volume":"39","author":"Platt","year":"2019","journal-title":"J Obstet Gynaecol"},{"key":"R21-20260518","doi-asserted-by":"crossref","first-page":"1242\u201358","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat Med"},{"key":"R22-20260518","first-page":"100081","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"261\u201367","DOI":"10.1016\/j.ejso.2021.09.008","article-title":"The impact of adjuvant hysterectomy on survival outcomes of patients with locally advanced cervical cancer: a network meta-analysis","volume":"48","author":"Pergialiotis","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"241\u201347","DOI":"10.1016\/0090-8258(89)90560-X","article-title":"Adenocarcinoma of the uterine cervix: prognostic factors and patterns of recurrence","volume":"33","author":"Goodman","year":"1989","journal-title":"Gynecol Oncol"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"208\u201312","DOI":"10.1016\/j.ygyno.2014.08.018","article-title":"Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiation","volume":"135","author":"Rose","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R26-20260518","doi-asserted-by":"crossref","first-page":"1001\u201310","DOI":"10.1016\/S1470-2045(09)70155-X","article-title":"Molecular predictive and prognostic markers in non-small-cell lung cancer","volume":"10","author":"Coate","year":"2009","journal-title":"Lancet Oncol"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"468\u201372","DOI":"10.1016\/j.radonc.2011.08.014","article-title":"Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis","volume":"100","author":"Schmid","year":"2011","journal-title":"Radiother Oncol"}],"updated-by":[{"DOI":"10.1097\/js9.0000000000005181","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000}}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003549","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:14:53Z","timestamp":1779110093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003549","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"2025-06-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}